Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Alcohol and liver].

H Fontaine1, A Vassault, B Nalpas

  • 1Unité d'Hépatologie, INSERM U 370, Hôpital Necker-Enfants Malades, Paris, France.

Pathologie-Biologie
|December 28, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 and chronic liver disease: results from the 1219 patients French registry.

Scientific reports·2025
Same author

Portal vein thrombosis as a long-term complication of chronic hepatosplenic candidiasis in an allogeneic haematopoietic stem-cell transplant recipient.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Letter: more studies are needed to elucidate the impact of HBV/HCV coinfection on cirrhosis and its consequences-Authors' reply.

Alimentary pharmacology & therapeutics·2018
Same author

The negative impact of HBV/HCV coinfection on cirrhosis and its consequences.

Alimentary pharmacology & therapeutics·2017
Same author

Reply to "A strong message is needed to address the issue of HCC recurrence after DAA therapy".

Journal of hepatology·2016
Same author

The relationship between liver stiffness measurement and outcome in patients with chronic hepatitis C and cirrhosis: a retrospective longitudinal hospital study.

Alimentary pharmacology & therapeutics·2016
Same journal

Pathologie-biologie·2020
Same journal

Antibacterial and antibiofilm activities of Laurus nobilis L. essential oil against Staphylococcus aureus strains associated with oral infections.

Pathologie-biologie·2015
Same journal

[Not Available].

Pathologie-biologie·2015
Same journal

Oxidative damage and histopathological changes in lung of rat chronically exposed to nicotine alone or associated to ethanol.

Pathologie-biologie·2015
Same journal

Biological diagnosis of diabetes mellitus.

Pathologie-biologie·2015
Same journal

Association of CagPAI integrity with severeness of Helicobacter pylori infection in patients with gastritis.

Pathologie-biologie·2015
See all related articles

This review covers alcohol metabolism, its liver damage mechanisms, and clinical alcohol-related liver disease (ARLD) patterns. It also details serum markers for screening alcohol abuse versus monitoring withdrawal and early liver disease.

Area of Science:

  • Hepatology
  • Toxicology
  • Clinical Biochemistry

Context:

  • Alcohol consumption is a leading cause of liver disease globally.
  • Understanding alcohol's impact on the liver is crucial for diagnosis and management.
  • Alcohol-related liver disease (ARLD) encompasses a spectrum of conditions.

Purpose:

  • To elucidate the metabolic pathways of alcohol and its hepatotoxic mechanisms.
  • To describe the clinical manifestations of diverse ARLD presentations.
  • To evaluate the utility and limitations of serum biomarkers in ARLD.

Summary:

  • The article details alcohol metabolism and its direct damage to the liver.
  • It outlines the clinical features associated with various forms of ARLD.
  • Key serum markers for alcohol abuse screening (e.g., GGT, CDT) are differentiated from those for monitoring withdrawal and early liver damage (e.g., ALT, AST, alphaGST).

Related Experiment Videos

Impact:

  • Provides a comprehensive overview of alcohol's effects on liver health.
  • Aids clinicians in differentiating diagnostic and monitoring strategies for ARLD.
  • Enhances understanding of biomarker selection for alcohol abuse and liver disease assessment.